Galangal extract with hypoglycemic activity and preparation method thereof

Through thermal reflux extraction of ethanol solution, dilute alkali alcohol refrigeration and column purification, the extraction process of galangal extract was optimized, and the problems of low extraction rate and low purity were solved, and high content extract was obtained, achieving effective reduction of galangal ginger Research and application of sugar activity.

CN118948984APending Publication Date: 2024-11-15JING BRAND +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411390564.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-08
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The existing extraction, separation and purification processes of galangal extracts have problems with low extraction rate and low purity, which hinders the in-depth research and application of total galangal flavonoids.

Method used

Using the thermal reflux extraction method of ethanol solution, dilute alkali alcohol refrigeration method and column purification method, through multi-step concentration, elution and drying treatment, a high content of galangal extract, including thermal reflux extraction, freeze-drying and resin column or Glucan gel chromatography column purification, optimized extraction conditions to increase total flavonoid content.

Benefits of technology

The high-active ingredient extraction of galangal extract is achieved, with simple process and convenient operation, suitable for large-scale production. The extract's hypoglycemic activity is better than similar studies, and the correlation between hypoglycemic activity and flavonoid content is clarified.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948984A_ABST
    Figure CN118948984A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of natural medicine, and particularly provides a galangal extract with hypoglycemic activity and a preparation method and application thereof.The preparation method comprises the steps of galangal crude extract preparation, crude extract purification and resin column or gel purification, the obtained galangal extract and purified product has good hypoglycemic activity and certain antioxidant activity, and the galangal extract and purified product can be used for preparing hypoglycemic drugs. Components and component markers, related to the hypoglycemic activity, of the extract are determined. The purified product has the effect of inhibiting the activity of alpha-glucosidase, can effectively inhibit the activity of related enzymes in a blood glucose generation and metabolism pathway and delay the blood glucose rising rate, and has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of natural medicines, and in particular to an Alpinia officinalis extract with hypoglycemic activity and a preparation method thereof. Background Art

[0002] Alpinia officinarum Hance is the dried rhizome of Alpinia officinarum Hance, a plant of the ginger family. It is dug up in late summer and early autumn, the fibrous roots and residual scales are removed, washed, cut into sections, and dried. The ethanol extract of Alpinia officinarum Hance was systematically separated using modern chromatography technology, from which 54 compounds including diarylheptanoids, flavonoids, glycosides, sesquiterpenes, and organic acids were obtained. In addition to proteins and carbohydrates, the main nutrients of Alpinia officinarum Hance also contain flavonoids, diarylheptanoids, volatile oils, phenylpropanoids, sterols, glycosides, trace elements, etc. with biologically active functions. Among them, Alpinia officinarum flavonoids is one of the most important active ingredients in Alpinia officinarum, which has multiple physiological activities such as lowering blood sugar, lowering blood pressure, and preventing cancer.

[0003] Most of the studies on the hypoglycemic activity of Alpinia officinarum are holistic studies, that is, the overall hypoglycemic activity of Alpinia officinarum extracts is analyzed without in-depth component analysis; a small number of studies have clear component objects, but the components covered are relatively few, and no systematic and comprehensive activity-component correlation analysis is conducted. One of the reasons why the current hypoglycemic activity analysis of Alpinia officinarum extracts is not in-depth is that there are many deficiencies and shortcomings in the extraction, separation, and purification processes of Alpinia officinarum extracts, especially the flavonoid components therein. For example, the extraction rates of solvent extraction, ultrasound, microwave, supercritical fluid extraction, etc. are all low, and there is a lack of effective separation and purification methods, resulting in low purity of the extracted total flavonoids of Alpinia officinarum, which hinders further research on total flavonoids of Alpinia officinarum.

[0004] In view of this, an optimized extraction and preparation process of Alpinia officinalis extract and application of the Alpinia officinalis extract obtained by the process are continued. Summary of the invention

[0005] In view of this, the present invention proposes a preparation method of an Alpinia officinalis extract with a higher total flavonoid content, as well as the extract and application thereof.

[0006] In a first aspect, the present invention provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0007] Step 1: Take dried Alpinia officinalis stems, crush and sieve them, extract them with ethanol solution under hot reflux, collect and combine the filtrate, concentrate and dry them to obtain a first crude extract;

[0008] Step 2: adding the crude extract to a hot dilute alkali alcohol solution until it is saturated and in excess, refrigerating at 4°C, and then filtering with suction. After the filtrate returns to room temperature, adding dilute acid dropwise to adjust the pH value to neutral, and freeze-drying to obtain a second crude extract;

[0009] Step 3: dissolving the second crude extract and purifying it through a column, eluting it with different eluents in turn, collecting the effluent and different eluents respectively, concentrating and drying them respectively to obtain the effluent and different eluted purified products, and obtaining the galangal extract.

[0010] In some embodiments, step three includes taking the second crude extract, ultrasonically mixing it with purified water, and then filtering it, purifying the filtrate on a resin column, eluting it with water and ethanol solution in sequence, collecting the effluent, water washing liquid and ethanol eluate respectively, and concentrating and drying them respectively to obtain an effluent, a water eluate and a purified galangal resin product, wherein the effluent, the water eluate and the purified galangal resin product are galangal extracts.

[0011] In some embodiments, the resin column is AB-8 or D101, the loading rate is 1-2 BV / h, the ethanol elution concentration is 50%-70%, the elution rate of water and ethanol is 1-2 BV / h, and the elution volume is 4-6 BV.

[0012] In some embodiments, the step three includes taking the second crude extract, dissolving it in dilute alcohol and then filtering it, purifying the filtrate through a dextran gel chromatography column, eluting it with alcohol solutions of different concentrations in turn, collecting the eluate and concentrating and drying it to obtain alcohol eluates of different concentrations, and the alcohol eluates of different concentrations are galangal extracts.

[0013] In some embodiments, the dextran gel chromatography column is Sephadex LH-20, the diluted alcohol for dissolution is 10% methanol or 10% ethanol, the alcohol solutions of different concentrations used for elution are the same as the diluted alcohol for dissolution, the elution volume is 1BV, and the elution flow rate is 1BV / h.

[0014] In some embodiments, in step three, the alcohol solutions of different concentrations used for elution include alcohol solutions of concentrations of 10%, 30%, 50%, 70% and 90% in sequence.

[0015] In some embodiments, in step one, the concentration of ethanol used for hot reflux extraction is 40%-90%, the mass volume ratio of galangal to the ethanol solution for extraction is 1:(5-30), the extraction temperature is 40-90°C, the extraction time is 60-180min, and the number of extractions is 1-3 times.

[0016] In some embodiments, in step 2, the mass ratio of the alkali in the dilute alkali-alcohol solution is less than 1%, the alkali is at least one of sodium hydroxide, potassium hydroxide, sodium carbonate, and sodium bicarbonate, the alcohol is 75%-90% ethanol, the temperature of the dilute alkali-alcohol solution is 75-90°C, the refrigeration time is 20-24h, and the dilute acid is dilute hydrochloric acid or dilute acetic acid with a mass fraction of less than 1%.

[0017] In a second aspect, the present invention further provides an Alpinia officinalis extract having hypoglycemic activity, which is prepared by the above-mentioned preparation method.

[0018] In a third aspect, the present invention also provides an application of the above-mentioned Alpinia officinalis extract with hypoglycemic activity, which is used for preparing hypoglycemic drugs.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] The preparation method of the present invention has a simple process, strong operability and convenient extraction conditions. The present invention adopts ethanol solution as a solvent, and an extract with high active ingredients can be obtained through simple hot reflux extraction, separation and purification. The process operation is simple, the repeatability is strong, and it can be used for actual large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0022] Figure 1 This is an analysis chart of the inhibition rate of α-glucosidase by different galangal samples in Example 4 of the present invention;

[0023] Figure 2 This is a graph showing the total flavonoid content analysis of different galangal samples in Example 4 of the present invention;

[0024] Figure 3 This is a fitting coefficient diagram of the PLS regression analysis model for the hypoglycemic activity and components of Alpinia officinalis in Example 5 of the present invention;

[0025] Figure 4 is a regression coefficient diagram between the hypoglycemic activity of Alpinia officinalis and the components in Example 5 of the present invention;

[0026] Figure 5 VIP value diagram between the hypoglycemic activity of Alpinia officinalis and the components in Example 5 of the present invention;

[0027] Figure 6 This is a graph showing the effect of different ethanol concentrations on the extraction yield of total flavonoids from Alpinia officinarum in Example 6 of the present invention;

[0028] Figure 7 This is a graph showing the effect of different night-feed material ratios on the extraction yield of total flavonoids from Alpinia officinalis in Example 6 of the present invention;

[0029] Figure 8 This is a graph showing the effect of different extraction temperatures on the extraction yield of total flavonoids from Alpinia officinarum in Example 6 of the present invention;

[0030] Fig. 9 This is a graph showing the effect of different extraction times on the extraction yield of total flavonoids from Alpinia officinalis in Example 6 of the present invention.

[0031] in:

[0032] Figure 1 The mass concentration of the sample was 0.01 mg / mL, and the extract was the second crude extract of Alpinia officinalis;

[0033] Figure 1 and Figure 2 The total flavonoids content and hypoglycemic activity (inhibition rate) of the samples were in a corresponding relationship; DETAILED DESCRIPTION

[0034] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0035] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of this application, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.

[0036] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the embodiments of the present invention belong. If the definitions set forth in this section are contrary to or otherwise inconsistent with the definitions set forth in the patents, patent applications, published patent applications, and other publications incorporated herein by reference, the definitions listed in this section take precedence over the definitions incorporated herein by reference.

[0037] Unless otherwise specified, the methods used in the following examples are all conventional methods. Unless otherwise specified, the materials, reagents and instruments used are all conventional materials, reagents and instruments in the art, and can be obtained by those skilled in the art through commercial channels.

[0038] When an amount, concentration or other value or parameter is expressed as a range, a preferred range or a range defined by a series of upper preferred values ​​and lower preferred values, this should be understood as specifically disclosing all ranges formed by any pairing of any range upper limit or preferred value with any range lower limit or preferred value, regardless of whether the range is disclosed separately. For example, when a range of "1 to 5" is disclosed, the described range should be interpreted as including the range "1 to 4", "1 to 3", "1 to 2", "1 to 2 and 4 to 5", "1 to 3 and 5", etc. When a numerical range is described herein, unless otherwise stated, the range is intended to include its end values ​​and all integers and fractions within the range. In the present specification and claims, range definitions can be combined and / or interchanged, and if not otherwise stated, these ranges include all subranges contained therein.

[0039] Regarding the relevant patents and studies that have been published so far, on the one hand, most of them are general studies on the hypoglycemic activity of Alpinia galanga, and the extracts are evaluated for biological activity after extraction, separation and purification, without in-depth analysis of the components; on the other hand, the extract prepared in this study has stronger hypoglycemic activity, and compared with the same positive control acarbose, the hypoglycemic activity and IC50 value of Alpinia galanga extract and Alpinia galanga purified product in this method are better than those of similar studies; at the same time, this method conducts a correlation analysis on activity-component, clarifies the components of Alpinia galanga related to hypoglycemic activity and the marker compounds that have a greater impact on hypoglycemic activity, which provides a more powerful theoretical guidance for the extraction process of Alpinia galanga and the application of extracts.

[0040] The preparation method of the galangal extract proposed in the present application comprises the following steps:

[0041] Step 1: Take dried Alpinia officinalis stems, crush and sieve them, extract them with ethanol solution under hot reflux, collect and combine the filtrate, concentrate and dry them to obtain a first crude extract;

[0042] Step 2: adding the crude extract to a hot dilute alkali alcohol solution until it is saturated and in excess, refrigerating at 4°C, and then filtering with suction. After the filtrate returns to room temperature, adding dilute acid dropwise to adjust the pH value to neutral, and freeze-drying to obtain a second crude extract;

[0043] Step 3: dissolving the second crude extract and purifying it through a column, eluting it with different eluents in turn, collecting the effluent and different eluents respectively, concentrating and drying them respectively to obtain the effluent and different eluted purified products, and obtaining the galangal extract.

[0044] Among them, step three can be performed in the following two ways:

[0045] First, the second crude extract is taken, ultrasonically mixed with purified water, and then filtered, the filtrate is purified on a resin column, eluted with water and ethanol solution in sequence, the effluent, water washing liquid and ethanol eluate are collected respectively, and the effluent, water eluate and galangal resin purified product are concentrated and dried respectively, and the effluent, water eluate and galangal resin purified product are galangal extract.

[0046] In method 1, the resin column is AB-8 or D101, the loading rate is 1-2 BV / h, the ethanol elution concentration is 50%-70%, the elution rate of water and ethanol is 1-2 BV / h, and the elution volume is 4-6 BV.

[0047] Secondly, the second crude extract is dissolved in dilute alcohol and then filtered, the filtrate is purified by a dextran gel chromatography column, eluted with alcohol solutions of different concentrations in turn, the eluate is collected and concentrated and dried to obtain alcohol eluates of different concentrations, and the alcohol eluates of different concentrations are galangal extracts.

[0048] In method 2, the dextran gel chromatography column is Sephadex LH-20, the diluted alcohol used for dissolution is 10% methanol or 10% ethanol, the alcohol solutions of different concentrations used for elution are the same as the diluted alcohol used for dissolution, the elution volume is 1BV, and the elution flow rate is 1BV / h.

[0049] For the preparation method of the galangal extract provided in the present application, and the prepared galangal extract, the present application also provides an in vitro hypoglycemic activity evaluation method:

[0050] Accurately weigh a certain amount of the first crude extract, the second crude extract, the effluent, the water eluate, the galangal resin purified product in method one and the dextran gel eluate eluted with different concentrations of alcohol solution in method two, and detect the flavonoid content with reference to the rutin method, and detect the hypoglycemic activity of samples of different concentrations with reference to the α-glucosidase inhibition rate determination method (i.e., the inhibition rate of α-glucosidase, the same below); the first crude extract a, the second crude extract b, and the galangal resin purified product c prepared by the above method have good hypoglycemic activity, and 0.02 mg / mL of each sample is effective for The inhibition rates of α-glucosidase activity were 49.87%, 57.84% and 97.01% respectively, and the inhibition rate of 10 mg / mL positive control acarbose was 45%±2%; the evaluation results of the hypoglycemic activity of dextran gel eluates eluted with different concentrations of alcohol at the same mass concentration showed that there was an obvious correlation trend between the total flavonoids content and the hypoglycemic activity in the samples. The higher the flavonoids content, the better the hypoglycemic activity. The analysis speculated that the total flavonoids were the main components of the hypoglycemic activity in Alpinia galanga, and the hypoglycemic activity had a certain correlation with the flavonoids content in the samples.

[0051] Detection method:

[0052] (1) Flavonoid content detection:

[0053] 1) Weigh 20 mg of rutin reference substance, place in a 50 mL volumetric flask, add an appropriate amount of methanol, ultrasonically dissolve, cool, add methanol to the scale, and shake well. Accurately measure 25 mL, place in a 50 mL volumetric flask, dilute to the scale with water, and shake well.

[0054] 2) Accurately measure 1mL, 2mL, 3mL, 4mL, 5mL, and 6mL of the diluted reference solution and place them in 25mL volumetric flasks respectively. Add water to 6mL each, add 1mL of 5% sodium nitrite solution, mix well, and let stand for 6 minutes. Add 1mL of 10% aluminum nitrate solution, shake well, and let stand for 6 minutes. Add 10mL of 4% sodium hydroxide test solution, add water to the scale, shake well, and let stand for 15 minutes. Using the corresponding reagent as the blank, measure the absorbance at a wavelength of 500nm according to the UV-Vis spectrophotometry, and draw a standard curve with absorbance as the ordinate and concentration as the abscissa.

[0055] 3) Weigh about 25 mg of sample, place in a 50 mL volumetric flask, add an appropriate amount of 60% ethanol, shake well, and ultrasonicate for 10 minutes to completely dissolve it. After cooling, make up to volume, filter, accurately measure 2 mL of filtrate, place in a 25 mL volumetric flask, and measure the absorbance according to the method under the preparation of standard curve, starting from "add water to 6 mL".

[0056] 4) Calculate the flavonoid content in the sample with reference to the standard curve.

[0057] (2) Determination of α-glucosidase inhibition rate:

[0058] 1) This method uses a 96-well plate and a multifunctional microplate reader to detect the change in the absorbance value of the sample at 405 nm to identify the decomposition rate of the substrate pNPG by α-glucosidase, thereby determining the degree of inhibition of α-glucosidase by different natural ingredients;

[0059] 2) Add 125 μL of 0.5M-pH6.8 phosphate buffer, 25 μL of sample or positive control acarbose, and 25 μL of α-glucosidase solution with a concentration of 1U / mL in sequence, place in a microplate reader and shake incubate at 31°C for 10 minutes, then take out, quickly add 25 μL of pNPG solution, and quickly place in the microplate reader (without covering the lid), start the experiment and continue detection for 90 minutes, with one cycle per minute;

[0060] 3) The net area under the curve of different samples was calculated by the instrument to obtain the inhibition rate of the samples on α-glucosidase, and a standard curve was drawn with different concentrations of positive control acarbose, and the acarbose concentration equivalents of samples with different concentrations were calculated by the standard curve.

[0061] Correlation analysis between galangal hypoglycemic activity and components:

[0062] The first crude extract, the second crude extract, the sample effluent, the water elution and the resin purification were prepared under different extraction conditions in multiple batches, and were recorded as #1 first crude extract, #1 second crude extract, #1 sample effluent, #1 water elution, #1 resin purification, #2 first crude extract, and so on. The components of each sample were analyzed, identified and located based on ultra-high performance liquid chromatography-quadrupole-time of flight high-resolution mass spectrometry and high-performance liquid chromatography. Preliminary analysis and identification suggested that Alpinia officinalis mainly contained galangin, proanthocyanidin B2, epicatechin, rutin, quercetin, naringenin, kaempferol, isorhamnetin, apigenin, galangin-3-methyl ether, protocatechin, ferulic acid, pyralidin, kaempferol-4'-O-methyl ether, curcumin, etc. 15 different batches of galangal extract, sample effluent, water washing and resin purified product with fixed concentration were prepared, and liquid phase content analysis and hypoglycemic activity analysis were performed respectively. The component content analysis was measured by HPLC peak area, and the hypoglycemic activity was measured by acarbose concentration equivalent calculated by reference to the positive control acarbose standard curve. The component-activity correlation analysis was performed, and the results of partial least squares regression analysis showed that 11 components including proanthocyanidin B2, epicatechin, rutin, quercetin, naringenin, kaempferol, galangin and galangin-3-methyl ether were positively correlated with the hypoglycemic activity of galangal. The VIP values ​​of galangin, kaempferol, proanthocyanidin B2 and epicatechin were greater than 1 (Variable Importance for the Projection), which were important markers affecting the hypoglycemic activity of galangal and had a high contribution to the activity.

[0063] The ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry conditions are as follows: chromatographic column-Waters ACQUITY UPLC HSS T3 C18 column (2.1×100 mm, 1.8 μm, SN: 02143826315152); mobile phase: 0.1% formic acid aqueous solution (A)-0.1% formic acid acetonitrile solution (B), gradient elution program is shown in the table below; flow rate: 0.4 mL / min; column temperature: 40°C; injection volume: 0.1 μL for reference and 0.5 μL for injection. Mass spectrometry conditions: ion source: electrospray ion source (ESI source); capillary voltage: 3.0 kV; ion source temperature: 120°C; desolvation temperature: 500°C; desolvation gas flow rate: high-purity nitrogen, flow rate of 800 L / Hr; collision gas: high-purity argon, pressure of 7 psi; collision energy: 6-40 eV.

[0064]

[0065] The conditions for high performance liquid chromatography component analysis are as follows: chromatographic column: Agilent ZORBAX SB-C18 analytical chromatographic column; mobile phase: methanol (A)-0.2% phosphoric acid (B) solution as mobile phase; flow rate: 1.0 mL·min-1; detection wavelength: 266 nm; column temperature: 30°C; injection volume: 10 μL; elution program is as follows:

[0066]

[0067] Example 1

[0068] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0069] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 0.5 kg of the sieved material, and extract twice with 50% ethanol solution, 2 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 10:1, the extraction temperature is 60°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain 87.1 g of the first crude extract of Alpinia officinalis;

[0070] (2) Initial purification of crude extract of Alpinia officinarum: Add the first crude extract of Alpinia officinarum to an appropriate amount of dilute alkali alcohol solution containing 0.8% NaOH-85% ethanol, heat the dilute alkali alcohol solution to 80°C in advance and keep it at a constant temperature, add the first crude extract of Alpinia officinarum to fully dissolve until saturated and in excess, cool to room temperature and place in a refrigerator at 4°C for 20 hours, filter quickly after the refrigeration, and add 0.5% HCl solution dropwise to adjust the pH to neutral after the filtrate returns to room temperature. Concentrate and freeze-dry the neutral filtrate to obtain 70.5 g of the second crude extract of Alpinia officinarum.

[0071] (3) Alpinia officinarum resin purification: Weigh 50 g of the second crude extract of Alpinia officinarum, dissolve it in 1.0 L of purified water by ultrasonication, and then apply it to an AB-8 resin column. Elute it with 2.0 L of water and 2.0 L of 60% ethanol solution in sequence at an elution rate of about 0.5 L / h. Collect the loading effluent, water washing liquid and ethanol eluent, concentrate and dry them to obtain 20.08 g, 8.83 g and 16.675 g of the loading effluent, water eluate and Alpinia officinarum resin purified product, respectively.

[0072] (4) α-glucosidase inhibition rate determination method:

[0073] 1) This method uses a 96-well plate and a multifunctional microplate reader to detect changes in the absorbance of the sample at 405 nm to identify the decomposition rate of the substrate pNPG by α-glucosidase, thereby determining the degree of inhibition of the action of different natural ingredients on α-glucosidase;

[0074] 2) Add 125 μL of 0.5M-pH6.8 phosphate buffer, 25 μL of sample or positive control acarbose, and 25 μL of α-glucosidase solution with a concentration of 1U / mL in sequence, place in a multifunctional microplate reader and incubate with shaking at 31°C for 10 minutes, then take out, quickly add 25 μL of pNPG solution, and quickly place in the microplate reader (without covering the lid), start the experiment and continue the detection for 90 minutes, with one cycle per minute.

[0075] (5) Evaluation of in vitro hypoglycemic activity of Alpinia officinalis extracts: 1 mg / mL Alpinia officinalis first crude extract, Alpinia officinalis second crude extract, sample effluent, water eluate and resin purified product were prepared respectively. The hypoglycemic activity of samples of different concentrations (i.e., the inhibition rate of α-glucosidase, the same below) was detected by referring to the α-glucosidase inhibition rate determination method. The Alpinia officinalis crude extract and resin purified product were diluted to gradient concentrations, and the inhibition rate of each sample at different concentrations was determined (the sample with an inhibition rate not exceeding 95% was an effective concentration). The inhibition rate-concentration relationship curve was drawn and the IC50 value was calculated. The results are shown in the following table:

[0076]

[0077] Example 2

[0078] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0079] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 0.6 kg of the sieved material, and extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain 115.1 g of the first crude extract of Alpinia officinalis;

[0080] (2) Initial purification of crude extract of Alpinia officinarum: Add the first crude extract of Alpinia officinarum to an appropriate amount of 1% NaCO3-90% dilute alkali ethanol solution, heat the dilute alkali alcohol solution to 85°C in advance and keep it at a constant temperature, add the first crude extract of Alpinia officinarum to dissolve until saturated and in excess, cool to room temperature and place in a refrigerator at 4°C for 24 hours, filter while cold after the refrigeration ends, add 0.8% dilute acetic acid solution dropwise to adjust the pH to neutral after the filtrate returns to room temperature, concentrate the neutral filtrate and freeze-dry to obtain 97.4g of the second crude extract of Alpinia officinarum.

[0081] (3) Alpinia officinarum resin purification: 50 g of the second crude extract of Alpinia officinarum was dissolved in 1.0 L of purified water and ultrasonically mixed, then purified on an AB-8 resin column and eluted with 2 L of water and 2 L of 60% ethanol solution, respectively, at an elution rate of 0.5 L / h. The sample effluent, water wash and ethanol eluate were collected, concentrated and dried to obtain 21.42 g, 6.98 g and 17.41 g of the sample effluent, water eluate and Alpinia officinarum resin purified product, respectively.

[0082] (4) α-glucosidase inhibition rate determination method:

[0083] 1) This method uses a 96-well plate and a multifunctional microplate reader to detect changes in the absorbance of the sample at 405 nm to identify the decomposition rate of the substrate pNPG by α-glucosidase, thereby determining the degree of inhibition of the effect of different natural ingredients on the action of α-glucosidase;

[0084] 2) Add 125 μL of 0.5M-pH6.8 phosphate buffer, 25 μL of sample or positive control acarbose, and 25 μL of α-glucosidase solution with a concentration of 1U / mL in sequence, place in a multifunctional microplate reader and incubate with shaking at 31°C for 10 minutes, then take out, quickly add 25 μL of pNPG solution, and quickly place in the microplate reader (without covering the lid), start the experiment and continue the detection for 90 minutes, with one cycle per minute.

[0085] (5) Evaluation of in vitro hypoglycemic activity of Alpinia officinalis extracts: 1 mg / mL Alpinia officinalis first crude extract, Alpinia officinalis second crude extract, sample effluent, water eluate and resin purified product were prepared respectively, and the hypoglycemic activity of samples of different concentrations was detected by referring to the α-glucosidase inhibition rate determination method. The results are shown in the following table:

[0086]

[0087] Example 3

[0088] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0089] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a No. 4 sieve of the pharmacopoeia, weigh 1.0 kg of the sieved material, and extract once with a 70% ethanol solution for 3 h / time, with a volume-to-mass ratio of ethanol solution to Alpinia officinalis of 15:1, and an extraction temperature of 75°C. After the extraction, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain 147.5 g of the first crude extract of Alpinia officinalis;

[0090] (2) Initial purification of crude extract of Alpinia officinarum: Add the first crude extract of Alpinia officinarum to an appropriate amount of a dilute alkali alcohol solution containing a mixture of 0.9% sodium carbonate and sodium hydroxide (4:1 mixture)-90% ethanol. The dilute alkali alcohol solution is heated to 85°C in advance and kept at a constant temperature. Add the first crude extract of Alpinia officinarum and dissolve it fully until it is saturated and in excess. After cooling to room temperature, place it in a refrigerator at 4°C for 24 hours. After the refrigeration is completed, filter it quickly. After the filtrate returns to room temperature, add a 1.0% dilute acetic acid solution dropwise to adjust the pH to neutral. The neutral filtrate is concentrated and freeze-dried to obtain 124.55 g of the second crude extract of Alpinia officinarum.

[0091] (3) Alpinia officinarum resin purification: Weigh 50 g of the second crude extract of Alpinia officinarum, dissolve it in 2 L of purified water by ultrasonication, and pass it through a D101 resin column. Elute it with 2.0 L of water and 2.0 L of 70% ethanol solution in sequence at an elution rate of about 0.5 L / h. Collect the load effluent, water wash and ethanol eluate, concentrate and dry them to obtain 18.21 g, 7.01 g and 19.19 g of the load effluent, water eluate and Alpinia officinarum resin purified product, respectively.

[0092] (4) α-glucosidase inhibition rate determination method:

[0093] 1) This method uses a 96-well plate and a Bioteck Synergy2 instrument to detect changes in the absorbance of the sample at 405 nm to identify the decomposition rate of the substrate pNPG (4-nitrophenyl β-D-glucuronide) by α-glucosidase, thereby determining the degree of inhibition of the effect of different natural ingredients on the action of α-glucosidase;

[0094] 2) Add 125 μL of 0.5M-pH6.8 phosphate buffer, 25 μL of sample or positive control acarbose, and 25 μL of α-glucosidase solution with a concentration of 1U / mL in sequence, place in a multifunctional microplate reader and incubate with shaking at 31°C for 10 minutes, then take out, quickly add 25 μL of pNPG solution, and quickly place in the microplate reader (without covering the lid), start the experiment and continue the detection for 90 minutes, with one cycle per minute.

[0095] (5) Evaluation of in vitro hypoglycemic activity of Alpinia officinalis extract: 1 mg / mL Alpinia officinalis crude extract, sample effluent, water eluate and resin purified product were prepared respectively, and the hypoglycemic activity of samples of different concentrations was detected by referring to the α-glucosidase inhibition rate determination method. The results are shown in the following table:

[0096]

[0097] Example 4

[0098] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity and a method for identifying its active components, comprising the following steps:

[0099] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stems, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, and extract it three times with a 55% ethanol solution, 2 h / time, the volume mass ratio of the ethanol solution to Alpinia officinalis is 25:1, the extraction temperature is 65°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain 152.9 of the first crude extract of Alpinia officinalis;

[0100] (2) Initial purification of crude extract of Alpinia officinarum: Add the first crude extract of Alpinia officinarum to an appropriate amount of a dilute alkali alcohol solution containing a mixture of 0.9% sodium carbonate and sodium hydroxide (4:1 mixture)-90% ethanol. The dilute alkali alcohol solution is heated to 85°C in advance and kept at a constant temperature. Add the first crude extract of Alpinia officinarum and dissolve it fully until it is saturated and in excess. After cooling to room temperature, place it in a refrigerator at 4°C for 24 hours. After the refrigeration is completed, filter it quickly. After the filtrate returns to room temperature, add a 1.0% dilute acetic acid solution dropwise to adjust the pH to neutral. The neutral filtrate is concentrated and freeze-dried to obtain 112.28 g of the second crude extract of Alpinia officinarum.

[0101] (3) Alpinia officinalis resin purification: Weigh 50 g of crude extract of Alpinia officinalis, dissolve and mix with 2 L of purified water by ultrasonication, and then pass it through an AB-8 resin column at a loading rate of 1 BV / h; first elute with purified water until the effluent is not obviously turbid, at an elution rate of 1-2 BV / h, and then elute with 3 L of 70% ethanol solution, at an elution rate of 1-2 BV / h, collect the loading effluent, water washing liquid and ethanol eluate respectively, and concentrate and dry to obtain each elution effluent.

[0102] (4) Alpinia officinalis glucan gel purification: accurately weigh 3.0 g of ethanol eluate, dissolve in 5 mL of 10% methanol ultrasonically, mix well, and centrifuge. Take the supernatant and slowly add it along the side wall of the pretreated glucan gel Sephadex LH-20 chromatography column. Then elute with 10%, 30%, 50%, 70%, and 90% methanol solutions in sequence, each concentration is 100 mL, the maximum natural flow rate, collect the eluate, concentrate and dry the eluate to obtain different concentrations of alcohol eluate, which are recorded as A-10%, A-30%, A-50%, A-70%, and A-90%, respectively;

[0103] (5) Detection of total flavonoid content and in vitro hypoglycemic activity: Prepare crude extract of galangal, sample effluent, water eluate, resin purified product and dextran gel eluate eluted with different concentrations of methanol at the same concentration, respectively. Detect the flavonoid content according to the rutin method, and detect the hypoglycemic activity (i.e., α-glucosidase inhibition rate) of samples of different concentrations according to the α-glucosidase inhibition rate determination method. Dilute the samples step by step until the inhibition rate is lower than 95%.

[0104] (6) Detection method:

[0105] ① Flavonoid content detection:

[0106] 1) Weigh 20 mg of rutin reference substance, place in a 50 mL volumetric flask, add an appropriate amount of methanol, sonicate to dissolve, cool, add methanol to scale, and shake well. Accurately measure 25 mL, place in a 50 mL volumetric flask, dilute to scale with water, and shake well.

[0107] 2) Accurately measure 1mL, 2mL, 3mL, 4mL, 5mL, and 6mL of the diluted reference solution and place them in 25mL volumetric flasks respectively. Add water to 6.0mL each, add 1mL of 5% sodium nitrite solution, mix well, and let stand for 6 minutes. Add 1mL of 10% aluminum nitrate solution, shake well, and let stand for 6 minutes. Add 10mL of 4% sodium hydroxide test solution, add water to the scale, shake well, and let stand for 15 minutes. Using the corresponding reagent as the blank, measure the absorbance at a wavelength of 500nm according to the UV-Vis spectrophotometry, and draw a standard curve with absorbance as the ordinate and concentration as the abscissa.

[0108] 3) Weigh about 25 mg of the test sample and place it in a 50 mL volumetric flask. Add an appropriate amount of 60% ethanol, shake well, and ultrasonically treat for 10 minutes to completely dissolve it. After cooling, make up to volume, filter, accurately measure 2 mL of the filtrate, and place it in a 25 mL volumetric flask. According to the method under the preparation of the standard curve, starting from "add water to 6 mL", determine the absorbance according to the method.

[0109] 4) Calculate the flavonoid content in the test sample with reference to the standard curve.

[0110] ② Determination of α-glucosidase inhibition rate:

[0111] 1) This method uses a 96-well plate and a multifunctional microplate reader to detect changes in the absorbance of the sample at 405 nm to identify the decomposition rate of the substrate pNPG by α-glucosidase, thereby determining the degree of inhibition of the effect of different natural ingredients on the action of α-glucosidase;

[0112] 2) Add 125 μL of 0.5M-pH6.8 phosphate buffer, 25 μL of sample or positive control acarbose, and 25 μL of α-glucosidase solution with a concentration of 1U / mL in sequence, place in a multifunctional microplate reader and incubate at 31°C with shaking for 10 min, then take out, quickly add 25 μL of pNPG solution, and quickly place in the microplate reader (without covering the lid), start the experiment and continue the detection for 90 min, with one cycle per minute;

[0113] 3) The net area under the curve of different samples is calculated by the instrument to obtain the inhibition rate of the samples on α-glucosidase.

[0114] (7) Analysis of the identification of hypoglycemic active components of Alpinia officinalis: The total flavonoid content and hypoglycemic activity at a certain concentration in different samples were determined by referring to the detection method in step (5). The total flavonoid content and hypoglycemic activity (inhibition rate) of each sample were compared. It was found that the hypoglycemic activity of each Alpinia officinalis sample showed a certain correlation trend with the total flavonoid content. The comparison diagram is as follows: Figure 1 and Figure 2 shown.

[0115] According to the data comparison in the figure, it can be seen that the higher the total flavonoids content in the sample, the higher the inhibition rate of the sample on α-glucosidase at the same concentration. It is speculated that the total flavonoids of Alpinia galanga have a more obvious effect on its hypoglycemic activity. By performing Pearson correlation analysis on the total flavonoids content and hypoglycemic activity (inhibition rate) in the sample, it can be concluded that the correlation coefficient between the flavonoids content and the hypoglycemic activity is 0.795, and the significant P value is 0.01, indicating that there is a significant correlation between the total flavonoids content and the hypoglycemic activity (inhibition rate). It can be concluded that the total flavonoids of Alpinia galanga are the main components affecting its hypoglycemic activity. The results of Pearson correlation analysis are shown in the following table:

[0116]

[0117] Note: ***, **, * represent 1%, 5%, 10% significance levels respectively

[0118] Example 5

[0119] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity and a method for identifying its active components, comprising the following steps:

[0120] (1) Preparation of Alpinia officinalis extract: Referring to the preparation method of Alpinia officinalis extract in Examples 1, 2 and 3, differentiated extraction and separation conditions were selected to prepare three batches of Alpinia officinalis extract (crude extract), loading effluent, water eluate and resin purified product under different conditions, which were respectively recorded as batches 1, 2 and 3, i.e., batches #1, #2 and #3.

[0121] (2) Evaluation of in vitro hypoglycemic activity of each batch of samples: The hypoglycemic activity of each sample was evaluated by referring to the α-glucosidase inhibition rate determination method in Example 4; and acarbose was used as a positive control to determine and draw a standard curve of acarbose concentration-inhibition rate. The hypoglycemic activity of each sample was calculated based on the standard curve, which was equivalent to the standard equivalent of acarbose, and this was used as an indicator of the hypoglycemic activity of each sample.

[0122] (3) Analysis and identification of ingredients of Alpinia officinalis: Using the batches of samples prepared in step (1) as raw materials, the ingredients of each sample were analyzed, identified and located based on ultra-high performance liquid chromatography-quadrupole-time of flight high-resolution mass spectrometry and high performance liquid chromatography. Preliminary analysis and identification suggested that Alpinia officinalis mainly contains 15 ingredients, including galangin, proanthocyanidin B2, epicatechin, rutin, quercetin, naringenin, kaempferol, isorhamnetin, apigenin, galangin-3-methyl ether, protocatechin, ferulic acid, pinot nouril, kaempferol-4'-O-methyl ether and curcumin. The basic information of HPLC is shown in the following table (where curcumin is added after the reference material).

[0123]

[0124]

[0125] The ultra-high performance liquid chromatography-quadrupole-time-of-flight high-resolution mass spectrometry conditions are as follows: chromatographic column-Waters T3C18 column (2.1×100 mm, 1.8 μm); mobile phase: 0.1% formic acid aqueous solution (A)-0.1% formic acid acetonitrile solution (B), gradient elution program is shown in the table below; flow rate: 0.4 mL / min; column temperature: 40°C; injection volume: 0.1 μL for reference sample, 0.5 μL for injection. Mass spectrometry conditions: ion source: electrospray ion source (ESI source); capillary voltage: 3.0 kV; ion source temperature: 120°C; desolvation temperature: 500°C; desolvation gas flow rate: high-purity nitrogen, flow rate of 800 L / Hr; collision gas: high-purity argon, pressure of 7 psi; collision energy: 6-40 eV.

[0126]

[0127] The conditions for high performance liquid chromatography component analysis are as follows: chromatographic column: Agilent ZORBAX SB-C18 analytical chromatographic column; mobile phase: methanol (A)-0.2% phosphoric acid (B) solution as mobile phase; flow rate: 1.0 mL·min-1; detection wavelength: 266 nm; column temperature: 30°C; injection volume: 10 μL; elution program is as follows:

[0128]

[0129] (4) Analysis of the correlation between components and activity of galangal: The samples with hypoglycemic activity determined in step (2) were used as unified samples for liquid phase content analysis. The component content analysis was measured by HPLC peak area, and the hypoglycemic activity was measured by the concentration equivalent of the positive control acarbose. The component-activity correlation analysis was performed. The results of partial least squares regression analysis showed that 11 components, including proanthocyanidin B2, epicatechin, rutin, quercetin, naringenin, kaempferol, galangin, and galangin-3-methyl ether, were positively correlated with the hypoglycemic activity of galangal. The VIP values ​​of galangin, kaempferol, proanthocyanidin B2, and epicatechin were greater than 1 (variable importance factor (Variable Importance for the Projection)), which are important markers affecting the hypoglycemic activity of galangal and have a high contribution to the activity. The results of partial least squares regression analysis are as follows: Figure 3-Figure 5 As shown:

[0130] Example 6

[0131] This embodiment provides an optimization process of various parameters in a method for preparing an Alpinia officinalis extract with hypoglycemic activity, comprising the following steps:

[0132] (1) Index analysis: The analysis in Example 4 clearly shows that total flavonoids of Alpinia officinalis are the main components that affect its hypoglycemic activity. Therefore, in order to obtain an Alpinia officinalis extract with high hypoglycemic activity, the relevant process parameters can be optimized based on the extraction rate of total flavonoids in Alpinia officinalis as an index. Since the four component indicators of key compounds related to activity, galangin, kaempferol, proanthocyanidin B2, and epicatechin may have different trends of change during the extraction process, and the indicators are not regular, the parameter optimization index this time is mainly based on total flavonoids, and the marker compounds related to activity can be used as the quality control standard of the extract;

[0133] (2) Single factor experiment of galangal extraction: 20g galangal powder was added with 10 times 50% ethanol and extracted at 60℃ for 2h. The extraction was performed once as the initial reference extraction condition. The solvent multiple, ethanol concentration, extraction temperature and extraction time were investigated respectively. The results are as follows: Figure 6-Figure 9 As shown;

[0134] (3) Orthogonal experiment of galangal extraction: Based on the results of the single factor optimization test, an orthogonal experiment was conducted with the extraction rate of total flavonoids from galangal as the evaluation index. The four factors of solvent multiple, ethanol concentration, extraction temperature, and extraction time were mainly investigated. Three levels were selected for each factor. The specific factor levels are shown in the table below:

[0135]

[0136] According to the orthogonal experimental design rules, a 4-factor 3-level L9 (34) orthogonal experimental table was designed. The specific experimental design table is shown below. Experiments were carried out according to each condition in the orthogonal experimental design table to detect the extraction rate of total flavonoids of Alpinia officinarum under each experimental group condition.

[0137]

[0138] From the test results in the table, it can be seen that the influence of each factor on the extraction rate of total flavonoids from Alpinia officinarum is in the following order: extraction temperature > ethanol concentration > liquid-to-solid ratio > extraction time. The mean analysis results show that A1B2C2D3 is the best combination of extraction conditions. The optimal extraction conditions for total flavonoids from Alpinia officinarum are preliminarily determined to be: ethanol concentration (60%), liquid-to-solid ratio (20BV), extraction temperature (70°C), and extraction time (2.5h).

[0139] (4) Active component identification method and application: The analysis in Example 4 clearly shows that total flavonoids of Alpinia galanga have a significant correlation with hypoglycemic activity and are the main components that affect the hypoglycemic activity of Alpinia galanga extracts; the 9 groups of extracts in the orthogonal experiment of step (5) of this example were fixed to the same volume with the addition of the minimum volume of solvent, mixed, and a certain volume of sample was measured and referred to the α-glucosidase inhibition rate determination method in Example 4. The sample activity was gradually diluted until it was not overloaded, and the hypoglycemic activity (inhibition rate) of each sample was evaluated. The comparison results of total flavonoid extraction rate and hypoglycemic activity are shown in the following table:

[0140]

[0141] Further Pearson correlation analysis was performed on the total flavonoids yield and hypoglycemic activity (inhibition rate) of Alpinia officinarum in the samples. It was found that the correlation coefficient between the flavonoids extraction yield (i.e., the extract with high flavonoids content) and the hypoglycemic activity was 0.83, and the significant P value was 0.006, indicating that the high-content flavonoids extract had better hypoglycemic activity. There was a certain correlation between the flavonoids content and the in vitro hypoglycemic activity (based on the α-glucosidase inhibitor model), and the correlation was strong. The flavonoids extraction yield can be used as an indicator for optimizing the extraction parameters of Alpinia officinarum, which has important application value for the extraction optimization of the hypoglycemic active components of Alpinia officinarum.

[0142]

[0143] Note: ***, **, * represent 1%, 5%, 10% significance levels respectively

[0144] Example 7

[0145] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0146] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0147] (2) Initial purification of the crude extract of Alpinia officinarum: add the first crude extract of Alpinia officinarum to an appropriate amount of a 1% NaCO3-90% dilute alkali ethanol solution, heat the dilute alkali alcohol solution to 80°C in advance and keep it at a constant temperature, add the first crude extract of Alpinia officinarum to dissolve until saturated and in excess, cool to room temperature and place in a refrigerator at 4°C for 24 hours, filter while cold after the refrigeration ends, add 0.8% dilute acetic acid solution dropwise to adjust the pH to neutral after the filtrate returns to room temperature, concentrate the neutral filtrate and freeze-dry to obtain the second crude extract of Alpinia officinarum.

[0148] The total flavonoids content in the second crude extract of Alpinia officinalis was detected and calculated to be 49.41%.

[0149] Example 8

[0150] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0151] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0152] (2) Initial purification of the crude extract of Alpinia officinarum: add the first crude extract of Alpinia officinarum to an appropriate amount of a 1% NaCO3-90% dilute alkali ethanol solution, heat the dilute alkali alcohol solution to 80°C in advance and keep it at a constant temperature, add the first crude extract of Alpinia officinarum to dissolve until saturated and in excess, cool to room temperature and place in a refrigerator at 4°C for 24 hours, filter while cold after the refrigeration ends, add 0.8% dilute acetic acid solution dropwise to adjust the pH to neutral after the filtrate returns to room temperature, concentrate the neutral filtrate and freeze-dry to obtain the second crude extract of Alpinia officinarum.

[0153] (3) Alpinia officinalis resin purification: 50 g of the second crude extract of Alpinia officinalis was dissolved in 1.0 L of purified water and ultrasonically mixed, and then purified on an AB-8 resin column. The column was eluted with 2 L of water and 2 L of 60% ethanol solution at a rate of 0.5 L / h. The ethanol eluate was collected, concentrated and dried to obtain the purified Alpinia officinalis resin.

[0154] The total flavonoid content in the purified galangal resin was detected and calculated to be 79.85%.

[0155] Example 9

[0156] This embodiment provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0157] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0158] (2) Initial purification of the crude extract of Alpinia officinarum: add the first crude extract of Alpinia officinarum to an appropriate amount of a 1% NaCO3-90% dilute alkali ethanol solution, heat the dilute alkali alcohol solution to 80°C in advance and keep it at a constant temperature, add the first crude extract of Alpinia officinarum to dissolve until saturated and in excess, cool to room temperature and place in a refrigerator at 4°C for 24 hours, filter while cold after the refrigeration ends, add 0.8% dilute acetic acid solution dropwise to adjust the pH to neutral after the filtrate returns to room temperature, concentrate the neutral filtrate and freeze-dry to obtain the second crude extract of Alpinia officinarum.

[0159] (3) Alpinia officinarum gel purification: 50 g of the second crude extract of Alpinia officinarum was dissolved and mixed by ultrasonication in 100 mL of 10% methanol, and then centrifuged. The supernatant was slowly added along the side wall of the pretreated Sephadex LH-20 chromatography column, and then eluted with 70% methanol solution in sequence, with an elution volume of 2 L and a maximum natural flow rate. The eluate was collected, concentrated and dried to obtain the Alpinia officinarum gel purified eluate.

[0160] The total flavonoid content in the purified eluate of Alpinia officinalis gel was detected and calculated to be 84.62%.

[0161] Comparative Example 1

[0162] This comparative example provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0163] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0164] The total flavonoids content in the first crude extract of Alpinia officinalis was detected and calculated to be 43.58%.

[0165] Comparative Example 2

[0166] This comparative example provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0167] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0168] (2) Alpinia officinalis resin purification: 50 g of the first crude extract of Alpinia officinalis was dissolved in 1.0 L of purified water and ultrasonically mixed, and then purified on an AB-8 resin column. The column was eluted with 2 L of water and 2 L of 60% ethanol solution at a rate of 0.5 L / h. The ethanol eluate was collected, concentrated and dried to obtain the purified Alpinia officinalis resin.

[0169] The total flavonoid content in the purified galangal resin was detected and calculated to be 74.27%.

[0170] Comparative Example 3

[0171] This comparative example provides a method for preparing an Alpinia officinalis extract having hypoglycemic activity, comprising the following steps:

[0172] (1) Preparation of crude extract of Alpinia officinalis: Slice and crush the dried Alpinia officinalis stem, pass through a pharmacopoeia No. 4 sieve, weigh 1.0 kg of the sieved material, extract twice with 60% ethanol solution, 2.5 h / time, the volume mass ratio of ethanol solution to Alpinia officinalis is 20:1, the extraction temperature is 70°C, after the extraction is completed, filter and combine the filtrate, and concentrate and dry the filtrate under reduced pressure to obtain the first crude extract of Alpinia officinalis;

[0173] (2) Alpinia officinarum gel purification: 50 g of the first crude extract of Alpinia officinarum was dissolved and mixed by ultrasonication in 100 mL of 10% methanol, and then centrifuged. The supernatant was slowly added along the side wall of the pretreated Sephadex LH-20 chromatography column, and then eluted with 70% methanol solution in sequence, with an elution volume of 2 L and a maximum natural flow rate. The eluate was collected, concentrated and dried to obtain the Alpinia officinarum gel purified eluate.

[0174] The total flavonoids content in the purified galangal gel was detected and calculated to be 79.02%.

[0175] It is not difficult to see from the comparison of the above Examples 7-9 and Comparative Examples 1-3 that the Alpinia officinalis extract or purified product obtained by the preparation scheme of the present application has a higher total flavonoid content than the Alpinia officinalis purified product obtained by the general extraction and purification process, and when preparing drugs or preparations with high-efficiency hypoglycemic activity, it has stronger specificity and better hypoglycemic activity.

[0176] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for preparing an extract of galangal with hypoglycemic activity, characterized in that: The steps include: Step 1: Take dried Alpinia officinalis stems, crush and sieve them, extract them with ethanol solution under hot reflux, collect and combine the filtrate, concentrate and dry them to obtain a first crude extract; Step 2: adding the crude extract to a hot dilute alkali alcohol solution until it is saturated and in excess, refrigerating at 4°C, and then filtering with suction. After the filtrate returns to room temperature, adding dilute acid dropwise to adjust the pH value to neutral, and freeze-drying to obtain a second crude extract; Step 3: dissolving the second crude extract and purifying it through a column, eluting it with different eluents in turn, collecting the effluent and different eluents respectively, concentrating and drying them respectively to obtain the effluent and different eluted purified products, and obtaining the galangal extract.

2. The method for preparing the galangal extract with hypoglycemic activity according to claim 1, characterized in that: The step three comprises: taking the second crude extract, ultrasonically mixing it with purified water, filtering it, purifying the filtrate on a resin column, eluting it with water and ethanol solution in sequence, collecting the effluent, the water washing liquid and the ethanol eluate respectively, and concentrating and drying them respectively to obtain the effluent, the water washing liquid and the galangal resin purified product, wherein the effluent, the water washing liquid and the galangal resin purified product are the galangal extract.

3. The method for preparing the galangal extract with hypoglycemic activity according to claim 2, characterized in that: The resin column is AB-8 or D101, the sample loading rate is 1-2BV / h, the ethanol elution concentration is 50%-70%, the elution rate of water and ethanol is 1-2BV / h, and the elution volume is 4-6BV.

4. The method for preparing the galangal extract with hypoglycemic activity according to claim 1, characterized in that: The step three comprises: taking the second crude extract, dissolving it in dilute alcohol and filtering it, purifying the filtrate through a dextran gel chromatography column, eluting it with alcohol solutions of different concentrations in turn, collecting the eluate and concentrating and drying it to obtain alcohol eluates of different concentrations, wherein the alcohol eluates of different concentrations are galangal extracts.

5. The method for preparing the galangal extract with hypoglycemic activity according to claim 4, characterized in that: The dextran gel chromatography column is Sephadex LH-20, the diluted alcohol used for dissolution is 10% methanol or 10% ethanol, the alcohol solutions of different concentrations used for elution are the same as the diluted alcohol used for dissolution, the elution volume is 1BV, and the elution flow rate is 1BV / h.

6. The method for preparing the galangal extract with hypoglycemic activity according to claim 4, characterized in that: In step three, the alcohol solutions of different concentrations used for elution include 10%, 30%, 50%, 70% and 90% alcohol solutions in sequence.

7. The method for preparing the galangal extract with hypoglycemic activity according to claim 1, characterized in that: In step 1, the concentration of ethanol used for hot reflux extraction is 40%-90%, the mass volume ratio of galangal to the ethanol solution for extraction is 1:(5-30), the extraction temperature is 40-90°C, the extraction time is 60-180min, and the number of extractions is 1-3 times.

8. The method for preparing the galangal extract with hypoglycemic activity according to claim 1, characterized in that: In step 2, the mass ratio of the alkali in the dilute alkali alcohol solution is less than 1%, the alkali is at least one of sodium hydroxide, potassium hydroxide, sodium carbonate, and sodium bicarbonate, the alcohol is 75%-90% ethanol, the temperature of the dilute alkali alcohol solution is 75-90° C., the refrigeration time is 20-24h, and the dilute acid is dilute hydrochloric acid or dilute acetic acid with a mass fraction of less than 1%.

9. A galangal extract having hypoglycemic activity, characterized in that: The galangal extract with hypoglycemic activity is prepared by the preparation method described in any one of claims 1 to 8.

10. A use of the galangal extract with hypoglycemic activity as claimed in claim 9, characterized in that: Used for preparing blood sugar lowering drugs or health food with auxiliary blood sugar lowering activity.

Citation Information

Patent Citations

  • Galangin extraction method

    CN104341379A

  • Preparation method of bioactivity extract from rhizoma alpiniae officinarum stems and leaves as well as extract containing flavone and application

    CN107998319A

  • Separation and purification method for extract of alpinia officinarum hance stems and leaves

    CN109691674A

  • Medicine containing galangin and preparation method thereof

    CN1879613A